drugset / Trial / NCT00454090
AZD8330 First Time in Man in Patients With Advanced Malignancies
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The primary purpose of this protocol is to investigate the safety and tolerability of AZD8330 (ARRY-424704) in patients with Advanced Malignancies
Timeline
- Start
- 2007-03
- Primary completion
- 2010-10
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD8330 | Small molecule | 0.5 mg | Oral |
| Subject | AZD8330 | Small molecule | 20 mg | Oral |
| Subject | AZD8330 | Small molecule | 40 mg | Oral |
| Subject | AZD8330 | Small molecule | 60 mg | Oral |